Product: | Delavirdine Mesylate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 8802 | ||||||||
CAS Number: | 147221-93-0 | ||||||||
Synonyms: | N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide mesylate | ||||||||
Pricing: |
|
||||||||
Formula: | C22H28N6O3S • CH3SO3H | ||||||||
Chemical Purity: | >98% | ||||||||
Molecular Weight: | 552.67 | ||||||||
Structure: | |||||||||
Appearance: | Solid | ||||||||
Category: | Anti-viral Compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
McCance-Katz, E.F., et al., Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine. Am. J. Addict. 15, 23-34, (2006); Scott, L.J., and Perry, C.M., Delavirdine: a review of its use in HIV infection. Drugs 60, 1411-1444, (2000) |
||||||||
MSDS: | |||||||||
Description: |
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) type 1. |